• Molecular NameGadodiamide
  • SynonymGadodiamide hydrate
  • Weight591.679
  • Drugbank_IDDB00225
  • ACS_NO122795-43-1
  • Show 2D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)-5.88
  • pkaN/A
  • LogD (pH=7, predicted)-10.41
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)0.38
  • LogSw (predicted, AB/LogsW2.0)7401690.0
  • Sw (mg/ml) (predicted, ACD/Labs)8.03
  • No.of HBond Donors3
  • No.of HBond Acceptors13
  • No.of Rotatable Bonds18
  • TPSA162.24
  • StatusFDA approved
  • AdministrationIV
  • PharmacologyA gadolinium-based contrast agent used in MR imaging procedures to assist in the visualization of blood vessels. It is commonly marketed under the trade name Omniscan.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding0.0
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • Metabollsmnot metabolized
  • Half life77.8 min
  • Excretionrenal
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A